RNAC · Cartesian Therapeutics, Inc. · Executive Compensation

$6.20 -0.21 (-3.28%)

Russell 2000 member Rebalance outlook locked

Market Cap

$193.94M

30.26M

Volume · Oct 23 85.73K Avg daily vol (3M) 131.68K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$674,000	—	$973,475	$2,314,320	$363,960	$4,113	$4,329,868
Metin Kurtoglu	M.D., Ph.D. Former Chief Technology Officer	$163,494	—	$775,931	$984,442	$60,427	$489,740	$2,474,034
Christopher Jewell	Former Chief Scientific Officer	$390,665	—	$375,046	$661,814	$144,200	$443,982	$2,015,707
Blaine Davis	Chief Financial Officer	$475,860	—	$372,460	$884,122	$205,572	$11,913	$1,949,927
Milos Miljkovic	Chief Medical Officer	$439,000	—	$321,670	$766,422	$118,530	$11,913	$1,657,535

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$642,720	—	$3,071,706	$3,138,074	$459,545	$2,166	$7,314,211
Blaine Davis	Chief Financial Officer	$462,000	—	$1,599,840	$1,634,460	$240,240	$34,872	$3,971,412
Metin Kurtoglu	M.D., Ph.D. Chief Technology Officer	$431,539	—	$1,010,460	$1,032,697	$228,800	$9,568	$2,713,064
Christopher Jewell	Chief Scientific Officer	$411,923	—	$513,612	$524,476	$218,400	$19,343	$1,687,754
Milos Miljkovic	Chief Medical Officer	$392,308	—	$361,812	$369,459	$208,000	$17,439	$1,349,018

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$618,228	$1,323,000	$319,564	$1,123,658	$343,200	$2,384,233	$6,111,883
Peter G. Traber	Former Chief Medical Officer	$458,920	$850,000	$226,000	$793,170	—	$1,452,830	$3,780,920
Lloyd Johnston	Former Chief Operations Officer	$431,336	$869,000	$113,000	$418,618	—	$865,636	$2,697,590
Blaine Davis	Chief Financial Officer	$440,000	$880,000	—	—	$176,000	$998,759	$2,494,759
Metin Kurtoglu	M.D., Ph.D. Chief Technology Officer	$50,313	—	—	—	$20,930	—	$71,243
Chris Jewell	Chief Scientific Officer	$37,500	—	—	—	$15,600	—	$53,100
Christopher Jewell	Chief Scientific Officer	$37,500	—	—	—	$15,600	—	$53,100

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$588,043	—	$749,053	$2,628,525	$325,655	$966	$4,292,242
Peter G. Traber	Former Chief Medical Officer	$455,573	—	$298,562	$1,035,133	$183,568	$31,147	$2,003,983
Kevin Tan	Former Chief Financial Officer	$425,769	—	$238,320	$846,225	$164,000	$14,115	$1,688,429
Takashi Kei Kishimoto	Chief Scientific Officer	$418,766	—	$238,320	$846,225	$169,120	$11,922	$1,684,353
Lloyd Johnston	Former Chief Operations Officer	$413,169	—	$238,320	$846,225	$166,400	$10,245	$1,674,359
Blaine Davis	Chief Financial Officer	$33,846	—	—	$1,228,750	—	$1,110	$1,263,706
Metin Kurtoglu	M.D., Ph.D. Chief Technology Officer	—	—	—	—	—	—	—
Chris Jewell	Chief Scientific Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$569,003	—	$720,529	$2,067,782	$313,115	$966	$3,671,395
Kevin Tan	Former Chief Financial Officer	$110,385	$75,000	—	$2,369,619	$46,280	$338	$2,601,622
Peter G. Traber	Chief Medical Officer	$440,000	—	$253,445	$704,679	$181,000	$21,561	$1,600,685
Takashi Kei Kishimoto	Chief Scientific Officer	$399,798	—	$214,133	$526,588	$160,000	$6,156	$1,306,675
Lloyd Johnston	Chief Operations Officer	$399,764	—	$214,133	$526,588	$160,000	$4,360	$1,304,845
Bradford D. Dahms	Chief Financial Officer	$183,206	—	$154,733	$526,588	—	$3,526	$868,053
Ann K. Donohue	C.P.A. VP, Finance and Corporate Controller, Principal Financial and Accounting Officer	$208,753	—	$12,708	$61,817	$74,250	$3,965	$361,493
Blaine Davis	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$550,000	$50,000	—	$1,178,324	$316,250	$773	$2,095,347
Peter G. Traber	Chief Medical Officer	$177,692	$75,000	—	$1,174,027	$84,333	$1,805	$1,512,857
Bradford D. Dahms	Chief Financial Officer	$370,577	$25,000	—	$323,644	$172,500	$67,635	$959,356
Lloyd Johnston	Chief Operations Officer	$384,537	—	—	$323,644	$176,952	$4,173	$889,306
Takashi Kei Kishimoto	Chief Scientific Officer	$386,703	—	—	$237,063	$177,949	$5,618	$807,333

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$550,000	—	—	$1,043,972	$275,000	$117,523	$1,986,495
Elona Kogan	General Counsel and Corporate Secretary	$296,692	$169,934	$197,000	$681,711	$10,066	$4,083	$1,359,486
Stephen Smolinski	Chief Commercial Officer	$332,092	—	—	$415,249	$132,837	$84,457	$964,635
Bradford D. Dahms	Chief Financial Officer	$113,077	$50,000	—	$499,753	$60,000	$45,774	$768,604

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Carsten Brunn	President and Chief Executive Officer	$42,308	$97,917	$1,055,250	$4,403,673	—	$6,000	$5,605,148
Stephen Smolinski	Chief Commercial Officer	$320,000	—	—	$745,431	$109,275	$62,244	$1,236,950

Executive changes

Person	Role	Change	Effective	Filed
Milos Miljkovic, M.D.	Chief Medical Officer	Resigned	2026-05-22	2026-05-26
Murat Kalayoglu, M.D., Ph.D.	member of the Board of Directors	Resigned	2026-03-31	2026-03-30
Adrian Bot, M.D., Ph.D.	Class II director	Appointed	2025-12-16	2025-12-18
Patrick Zenner, M.B.A.	Lead Independent Director of the Board	Appointed	—	2025-10-30
Kemal Malik, M.B.B.S.	Chairman of the Board’s Compensation Committee	Appointed	2025-10-29	2025-10-30
Patrick Zenner, M.B.A.	Lead Independent Director of the Board	Appointed	2025-10-29	2025-10-30
Carsten Brunn, Ph.D.	Chairman of the Board	Appointed	2025-10-29	2025-10-30
Carrie S. Cox	member of the Board of Directors	Resigned	2025-10-29	2025-10-30
Christopher Jewell, Ph.D.	Chief Scientific Officer	Terminated	2025-11-14	2025-10-21
June Seymour	Chief Accounting Officer	Appointed	2025-10-27	2025-10-08
Metin Kurtoglu	Chief Technology Officer	Terminated	2025-05-01	2025-04-29
Kemal Malik, MBBS	Board of Directors	Appointed	—	2024-07-02
Kemal Malik	Class II director	Appointed	2024-07-01	2024-07-02
Murat Kalayoglu, M.D., Ph.D.	Class II Director	Appointed	2024-06-14	2024-06-17
Carrie S. Cox	Class II Director	Appointed	2024-06-14	2024-06-17
Metin Kurtoglu, M.D., Ph.D.	Chief Operating Officer	Appointed	2023-11-13	2024-04-01
Aymeric Sallin	member of the Board of Directors	Resigned	2024-02-28	2024-03-05
Scott D. Myers	member of the Board of Directors	Resigned	2023-11-21	2023-11-27
Michael Singer	Director	Appointed	—	2023-11-13
Murat Kalayoglu	Director	Appointed	—	2023-11-13
Emily English	Vice President of Quality	Appointed	—	2023-11-13
Chris Jewell	Chief Scientific Officer	Appointed	—	2023-11-13
Milos Miljkovic	Chief Medical Officer	Appointed	—	2023-11-13
Metin Kurtoglu	Chief Operating Officer	Appointed	—	2023-11-13
Michael Singer	Class I director	Appointed	2023-11-13	2023-11-13

Leadership

Carsten Brunn CEO, Board Member
Carsten Brunn, Ph.D. Chairman
Blaine Davis CFO, Chief Accounting Officer
Kevin Tan CFO
Metin Kurtoglu COO
Metin Kurtoglu, M.D., Ph.D. COO
June Seymour Chief Accounting Officer
Adrian Bot Board Member
Adrian Bot, M.D., Ph.D. Board Member
Carrie S. Cox Board Member
Kemal Malik Board Member
Kemal Malik, M.B.B.S. Board Member
Kemal Malik, MBBS Board Member
Michael Singer Board Member
Michael Singer, M.D., Ph.D. Board Member
Murat Kalayoglu Board Member
Murat Kalayoglu, M.D., Ph.D. Board Member
Nishan de Silva Board Member
Nishan de Silva, M.D., M.B.A. Board Member
Patrick Zenner Board Member
Patrick Zenner, M.B.A. Board Member
Timothy A. Springer Board Member
Timothy C. Barabe Board Member

Key facts CIK 1453687 CUSIP 816212302 13F (30d) 12 filings 12 filers Visit website Investor relations